# FDA Inspection 1115148 - Regalabs - November 12, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/regalabs/2a65240a-0886-4163-b77c-c8999d9cddc3
Source feed: FDA_Inspections

> FDA Inspection 1115148 for Regalabs on November 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1115148
- Company Name: Regalabs
- Inspection Date: 2019-11-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1187535 - 2022-11-04](https://www.globalkeysolutions.net/records/fda_inspections/regalabs/b763b008-12ca-41ab-8e7a-22b9f9b78ef8)
- [FDA Inspection 1187535 - 2022-11-04](https://www.globalkeysolutions.net/records/fda_inspections/regalabs/fdcea48e-25fe-4e10-a61c-acf587b0f7cb)

Company: https://www.globalkeysolutions.net/companies/regalabs/848bfe03-e1d4-4df7-ac3f-7a427c8f10c3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c